These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23271763)

  • 1. You're kidding...I have cancer? A patient's perspective on coping with prostate cancer and why active surveillance was not chosen.
    Lipton DA
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):140-2. PubMed ID: 23271763
    [No Abstract]   [Full Text] [Related]  

  • 2. Treater to target: a urologist's personal experience with prostate cancer.
    Schellhammer PF
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):143-5. PubMed ID: 23271764
    [No Abstract]   [Full Text] [Related]  

  • 3. Decision-Making in Prostate Cancer: Active Surveillance Over Other Treatment Options.
    Bayliss D; Duff J; Stricker P; Walker K
    Urol Nurs; 2016; 36(3):141-9. PubMed ID: 27501595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
    Bayliss DR; Duff J; Stricker P; Walker K
    Urol Nurs; 2017; 37(1):15-22. PubMed ID: 29240360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
    Rittenmeyer L; Huffman D; Alagna M; Moore E
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment decision-making for localized prostate cancer: what younger men choose and why.
    Sidana A; Hernandez DJ; Feng Z; Partin AW; Trock BJ; Saha S; Epstein JI
    Prostate; 2012 Jan; 72(1):58-64. PubMed ID: 21520163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.
    Hoffman RM
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):197-201. PubMed ID: 23271773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.
    Donovan JL
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):191-6. PubMed ID: 23271772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
    Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert panel advocates surveillance for men with low-risk prostate cancer.
    Slomski A
    JAMA; 2012 Jan; 307(2):133. PubMed ID: 22235075
    [No Abstract]   [Full Text] [Related]  

  • 14. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer.
    Haffty BG; Lawton CA; Sandler H
    JAMA Oncol; 2015 Aug; 1(5):688-9. PubMed ID: 26182350
    [No Abstract]   [Full Text] [Related]  

  • 15. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply.
    Williams SB; Chamie K; Hu JC
    JAMA Oncol; 2015 Aug; 1(5):689-90. PubMed ID: 26181144
    [No Abstract]   [Full Text] [Related]  

  • 16. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
    Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
    BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-risk and very-low-risk prostate cancer: is there a role for focal therapy in the era of active surveillance? No, focal therapy provides a false sense of security and no proven benefits.
    Nelson JB
    Oncology (Williston Park); 2014 Nov; 28(11):951-C3. PubMed ID: 25741546
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate Cancer: Making Decisions About Treatment.
    Am Fam Physician; 2018 Jun; 97(12):Online. PubMed ID: 30216020
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living with untreated prostate cancer: predictors of quality of life.
    Bellardita L; Villa S; Valdagni R
    Curr Opin Urol; 2014 May; 24(3):311-7. PubMed ID: 24637318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.